RFG1 (Repressor of Filamentous Growth 1) is a DNA-binding protein that recruits the Tup1 corepressor to regulate hyphal-specific genes in C. albicans. It suppresses pseudohyphal growth under non-inducing conditions and works alongside Nrg1 and Tup1 to control ~50% of serum- and temperature-induced genes during morphogenesis .
Key Features of RFG1:
Domain Structure: Contains a DNA-binding domain and a repression domain that interacts with Tup1 .
Functional Role: Represses genes involved in cell division (e.g., CDC10, KIP4) and virulence factors (e.g., SAP proteases) .
Regulation: RFG1 repression is lifted during hyphal induction, though the exact mechanism remains unclear .
Hyphal-Specific Gene Control: RFG1-Tup1 represses 13 hyphal-specific genes, including PHR1 (pH-responsive) and HYR1 (hyphal cell wall protein) .
Overlap with Nrg1: 10 hyphal-specific genes are co-regulated by RFG1 and Nrg1, indicating partial functional redundancy .
Virulence Link: RFG1 deletion enhances filamentation but does not attenuate virulence in mouse models .
Epitope Accessibility: Structural studies suggest RFG1 adopts a closed conformation in solution, potentially shielding antibody-binding sites until activation .
Cross-Reactivity: Homologs of RFG1 in other fungi (e.g., S. cerevisiae) could complicate specificity .
Clinical Relevance: While RFG1 regulates virulence genes, its direct role in human infections remains unclear .
KEGG: cal:CAALFM_CR02640WA
ROX1 is a transcription factor that functions as a repressor of hypoxia-related genes during normoxia in fungi. In Candida glabrata, ROX1 contains an HMG DNA binding domain positioned at the C-terminus, which differs from Saccharomyces cerevisiae where the DNA binding domain is located at the N-terminus . Similar to its S. cerevisiae counterpart, C. glabrata ROX1 appears to repress genes involved in hypoxic response and cell wall maintenance. Transcriptional profiling has shown that when ROX1 is deleted, 90 genes are upregulated by 2-fold or more during log-phase growth, including 5 genes involved in hypoxic response and several cell wall-related genes, demonstrating conservation of function between S. cerevisiae and C. glabrata ROX1 .
Loss-of-function mutations in ROX1 have been shown to suppress fluconazole hypersusceptibility in C. glabrata strains lacking UPC2A (a transcriptional regulator of ergosterol biosynthesis). While upc2A deletion mutants show significant growth defects in the presence of fluconazole, the additional deletion of ROX1 in these strains partially restores growth in the presence of the antifungal agent . This mechanism appears to involve the restoration of ERG11 expression (the target of fluconazole) to nearly wild-type levels, coupled with reduced expression of ERG3 and ERG6 .
ROX1 mutations can be identified through whole-genome sequencing of resistant isolates, followed by targeted sequencing of the ROX1 gene to confirm the presence of mutations. Western blotting and quantitative RT-PCR are commonly used to analyze the downstream effects of ROX1 mutations on protein expression . Genetic manipulation techniques are employed to generate deletion mutants (rox1Δ) in different genetic backgrounds to confirm that loss-of-function mutations are responsible for observed phenotypes. Sterol profiling using gas chromatography-mass spectrometry (GC-MS) helps identify changes in sterol composition resulting from ROX1 mutations .
The relationship between ROX1 and UPC2A in regulating the ergosterol biosynthesis pathway is complex and goes beyond a simple repressor-activator dynamic. In C. glabrata, ROX1 appears to negatively regulate the expression of ergosterol biosynthesis genes, while UPC2A positively regulates them. When both regulators are deleted (rox1Δ upc2AΔ), the expression of different ERG genes is affected in distinct ways . For instance, in the absence of fluconazole, ERG11 expression is elevated 3.5-fold in the rox1Δ upc2AΔ mutant relative to wild type, suggesting the existence of at least one other positive transcriptional regulator besides UPC2A . In contrast, the expression of ERG6 is dramatically reduced in the rox1Δ upc2AΔ double mutant in the presence of fluconazole, indicating a strong negative genetic interaction between upc2AΔ and rox1Δ mutations with respect to ERG6 expression .
Sterol profiling reveals that rox1Δ upc2AΔ double mutants maintain wild-type levels of ergosterol even in the presence of fluconazole, whereas the upc2AΔ single mutant shows significantly reduced ergosterol content under the same conditions . This maintenance of ergosterol levels likely contributes to the double mutant's reduced susceptibility to fluconazole. The double mutant also shows altered levels of specific sterols:
| Sterol | Wild-type + FLC | rox1Δ upc2AΔ + FLC | Significance |
|---|---|---|---|
| Ergosterol | Depleted | Maintained at WT levels | Contributes to resistance |
| Zymosterol | Normal | Accumulated | Suggests reduced Erg6 activity |
| Lanosterol | Increased | Further increased | Indicates reduced conversion to eburicol |
| Eburicol | Present | Significantly reduced | Supports reduced Erg6 activity |
These changes in sterol composition, particularly the maintenance of ergosterol levels and alterations in the flux through specific enzymatic steps (especially reduced Erg6 activity), contribute to the fluconazole resistance phenotype observed in rox1Δ upc2AΔ strains .
Transcriptional profiling through RNA-Seq provides comprehensive insights into the genome-wide effects of ROX1 deletion in C. glabrata. This approach reveals that 90 genes are upregulated by at least 2-fold in the rox1Δ mutant during log-phase growth in rich medium . Gene Ontology (GO) term analysis of these upregulated genes shows enrichment for cell wall-related genes (corrected P = 3.4×10⁻⁴) and hypoxia-responsive genes, supporting the conservation of ROX1 function between C. glabrata and S. cerevisiae .
When comparing gene expression in the presence and absence of fluconazole, 93 genes are upregulated in the rox1Δ mutant under fluconazole exposure, with 48 genes remaining upregulated regardless of fluconazole presence and 42 genes specifically upregulated only in the presence of the drug . The latter set represents candidate genes that may be ROX1-regulated during sterol stress and is enriched for genes involved in carbohydrate metabolic processes (P = 7.7×10⁻⁴) and oxidation-reduction processes (P = 3.1×10⁻³) .
Rheumatoid factors (RF) are autoantibodies with specificity for the constant regions of IgG molecules. They are found in several immunopathological diseases, and their presence serves as an important biomarker in clinical settings . Despite their clinical importance, the mechanisms by which these autoantibodies are produced remain largely unknown. Research has shown that RF-like immune complexes (ICs) can induce an intense IgG1-antibody production with RF activity in mice, with this response being sustained for several months and differing from conventional immune responses to antigens or other immune complexes .
Mouse models have been widely employed to study RF production mechanisms. Researchers have demonstrated that a single injection of RF-like immune complexes into mice can selectively induce an intense IgG1-antibody production with RF activity . The NZB mouse strain has been particularly useful for studying RF responses, as it develops autoimmune manifestations similar to human systemic lupus erythematosus. Experimental approaches include the manipulation of specific immune components through antibody-mediated depletion (e.g., anti-CD4 antibodies to deplete CD4+ T cells), genetic knockouts (e.g., Fc gamma RI/III-deficient mice), and complement depletion using agents like Cobra venom factor .
CD4+ T cells play a critical role in the production of IgG1 RF in response to RF-like immune complexes. Studies using NZB mice treated with monoclonal antibodies against the CD4 molecule have demonstrated complete abrogation of IgG1 RF production . This finding indicates that the RF response is T cell-dependent, despite its unusual characteristics compared to conventional immune responses. The exact mechanisms by which CD4+ T cells contribute to RF production remain an area of active investigation, but likely involve helper functions for B cells producing the RF antibodies .
Fc gamma receptors (FcγRs) significantly impact RF antibody production. Research using mice deficient for FcγRI/III has shown a substantial decrease in both the number of IgG1 antibody-secreting cells and serum IgG1 RF levels compared to normal littermates following administration of RF-like immune complexes . This suggests that FcγRs are important for the recognition and processing of immune complexes that lead to RF production. The interaction between immune complexes and FcγRs likely initiates signaling cascades that ultimately result in the stimulation of RF-producing B cells .
The complement system appears to be involved in RF antibody production. Studies in complement-depleted NZB mice (using Cobra venom factor) compared to intact mice have investigated the IgG1 RF response following administration of RF-like immune complexes . While the specific results of complement depletion on RF production were not fully detailed in the available search results, the experimental approach demonstrates that complement is considered an important factor in RF generation mechanisms. Complement may facilitate the processing and presentation of immune complexes to relevant immune cells, thereby influencing the subsequent RF antibody response .
Several techniques are crucial for accurately quantifying gene expression changes in ROX1 studies:
Quantitative Reverse Transcription-PCR (qRT-PCR): This method provides sensitive and specific quantification of mRNA expression levels for individual genes of interest. In ROX1 research, qRT-PCR has been used to analyze the expression of ERG genes in various genetic backgrounds and under different growth conditions .
RNA-Seq: This technique enables genome-wide transcriptional profiling, allowing researchers to identify all genes regulated by ROX1. RNA-Seq has revealed that 90 genes are upregulated by at least 2-fold in rox1Δ mutants during log-phase growth .
Western Blotting: This protein detection method complements RNA-level analyses by confirming that changes in mRNA expression translate to altered protein levels. Western blotting has been used to analyze Erg11 protein levels in different C. glabrata strains, confirming the patterns observed at the RNA level .
Optimal sterol profiling for studying ROX1 mutations involves:
Growth Standardization: Ensuring consistent growth conditions for all strains being compared, including media composition, growth phase, and exposure time to antifungal agents if applicable.
Comprehensive Sterol Extraction: Using appropriate solvents and extraction techniques to ensure all cellular sterols are efficiently isolated from fungal cells.
Gas Chromatography-Mass Spectrometry (GC-MS): Employing high-resolution GC-MS to separate and identify individual sterol species, with particular attention to ergosterol and intermediates in the ergosterol biosynthesis pathway.
Quantitative Analysis: Using internal standards to enable accurate quantification of each sterol species relative to total sterols.
Statistical Validation: Employing appropriate statistical methods (e.g., ANOVA followed by Student t-tests with Bonferroni adjustment) to identify significant differences between strains .
When designing experiments to investigate immune complex-mediated RF production, researchers should consider:
Mouse Strain Selection: Different mouse strains may have varying propensities for RF production. NZB mice have been used successfully in RF research due to their autoimmune tendencies .
Immune Complex Preparation: The composition and size of RF-like immune complexes can significantly affect their immunogenicity. Standardization of immune complex preparation is essential for reproducible results.
Targeted Immune Component Depletion/Knockout: To elucidate the roles of specific immune components (e.g., CD4+ T cells, complement, Fc receptors), researchers can use antibody-mediated depletion, genetic knockouts, or pharmacological inhibition approaches .
Comprehensive Readouts: Measuring multiple parameters, including serum RF levels, numbers of antibody-secreting cells, and isotype distribution, provides a more complete picture of the RF response.
Kinetic Analysis: RF responses may evolve over time, so longitudinal sampling is important to capture the full dynamics of the response .